Cetrorelix in reproductive medicine
This book chapter presents the most important clinical aspects concerning the gonadotropin-releasing hormone antagonist cetrorelix and its importance in reproductive medicine. After an overview of the historical milestones in the development and establishment of cetrorelix in the context of ovarian...
Saved in:
Main Authors: | Sebastian Findeklee, M.D., Ph.D (Author), Prof Klaus Diedrich (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Uso de antagonista de GnRH (cetrorelix) em dose única para evitar ovulações prematuras em ciclos de fertilização assistida Single dose of GnRH antagonist (cetrorelix) to avoid premature ovulation in assisted fertilization cycles
by: Pedro Luís Rosan, et al.
Published: (2003) -
Cetrorelix suppresses the preovulatory LH surge and ovulation induced by ovulation-inducing factor (OIF) present in llama seminal plasma
by: Letelier Claudia, et al.
Published: (2011) -
Preliminary Report on the Effect of a Lower Dose of Gonadotropin-Releasing Hormone Antagonist (Cetrorelix) on Ovarian Hyperstimulation in Lower-Weight Asian Women
by: Yung-Ling Chang, et al.
Published: (2006) -
Endometrial receptivity tests in reproduction: a SWOT analysis
by: Juan A. Garcia-Velasco, MD, PhD, et al.
Published: (2023) -
Eliminating health inequities in reproductive medicine: ensuring care for all
by: Torie Comeaux Plowden, M.D., M.P.H, et al.
Published: (2022)